Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea · Delayed Price · Currency is KRW 2,760.00
-5.00 (-0.18%)
At close: Feb 27, 2026
Green Lifescience Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -365.54 | 1,562 | -16,358 | -3,526 | -3,136 | -1,059 |
Depreciation & Amortization | 764.55 | 768.54 | 2,476 | 2,769 | 2,565 | 2,668 |
Loss (Gain) From Sale of Assets | 0 | - | - | -1.39 | 2.24 | - |
Asset Writedown & Restructuring Costs | -1.24 | - | 12,095 | - | - | - |
Loss (Gain) From Sale of Investments | -288.47 | 144.81 | -43.71 | -694.8 | -416.74 | -636.86 |
Provision & Write-off of Bad Debts | -9.4 | 35.3 | 49.5 | -34.85 | 17.15 | -37.59 |
Other Operating Activities | -553.02 | -1,460 | 693.59 | 1,364 | -369.63 | 1,241 |
Change in Accounts Receivable | -5,061 | -3,500 | 984.56 | 871.71 | -1,716 | 3,714 |
Change in Inventory | -930.43 | 2,187 | 460.55 | -782.87 | 1,270 | -2,571 |
Change in Accounts Payable | 5,180 | 1,409 | -84.25 | -3,276 | 1,277 | 305.68 |
Change in Unearned Revenue | -5.3 | 12.71 | - | 34 | - | - |
Change in Other Net Operating Assets | 135.57 | -634.36 | 97.1 | -1,274 | 1,118 | -1,721 |
Operating Cash Flow | -1,134 | 525.49 | 370.02 | -4,552 | 611.38 | 1,902 |
Operating Cash Flow Growth | - | 42.02% | - | - | -67.86% | -55.15% |
Capital Expenditures | -350.04 | -780.62 | -495.69 | -1,478 | -3,444 | -2,667 |
Sale of Property, Plant & Equipment | 7.2 | - | - | 1.5 | 2.1 | - |
Sale (Purchase) of Intangibles | -359.85 | -60.3 | -10.2 | - | - | - |
Investment in Securities | 2,524 | 4,143 | 7,791 | 6,489 | 2,948 | -5,223 |
Other Investing Activities | -21.96 | -22.21 | 230.75 | 44.54 | -108.34 | - |
Investing Cash Flow | 1,800 | 3,280 | 7,516 | 5,057 | -602 | -7,890 |
Short-Term Debt Issued | - | - | 15,753 | 9,552 | 10,128 | 8,661 |
Total Debt Issued | 1,800 | - | 15,753 | 9,552 | 10,128 | 8,661 |
Short-Term Debt Repaid | - | - | -17,441 | -10,418 | -8,911 | -7,544 |
Long-Term Debt Repaid | - | -189.63 | -221.77 | -205.29 | -256.23 | -217.28 |
Total Debt Repaid | -93.46 | -189.63 | -17,663 | -10,623 | -9,167 | -7,761 |
Net Debt Issued (Repaid) | 1,707 | -189.63 | -1,910 | -1,071 | 961.34 | 899.98 |
Repurchase of Common Stock | - | -1,657 | -2,366 | - | - | - |
Other Financing Activities | -29 | -82 | -30.84 | 0 | -0 | - |
Financing Cash Flow | 1,678 | -1,928 | -4,307 | -1,071 | 961.34 | 899.98 |
Foreign Exchange Rate Adjustments | 641.23 | 843.02 | -45.14 | -7.69 | 15.17 | -23.34 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - |
Net Cash Flow | 2,984 | 2,720 | 3,533 | -573.99 | 985.91 | -5,112 |
Free Cash Flow | -1,484 | -255.13 | -125.67 | -6,030 | -2,832 | -765.1 |
Free Cash Flow Margin | -4.28% | -1.03% | -0.56% | -16.52% | -11.18% | -3.12% |
Free Cash Flow Per Share | -77.77 | -13.26 | -6.30 | -301.49 | -141.61 | -38.26 |
Cash Interest Paid | 282.16 | 234.3 | 226.53 | 163.84 | 18.33 | 27.14 |
Cash Income Tax Paid | - | -55.8 | -69.58 | 83.73 | -0.45 | -15.99 |
Levered Free Cash Flow | -1,306 | -848.11 | 812.18 | -4,933 | -1,743 | -900.07 |
Unlevered Free Cash Flow | -1,131 | -699.32 | 962.45 | -4,862 | -1,730 | -888.27 |
Change in Working Capital | -681.22 | -525.36 | 1,458 | -4,428 | 1,949 | -272.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.